Notably, high SYT11 expression in other cancer types, such as Adrenocortical Cancer, Bladder Cancer, Acute Myeloid Leukemia, Mesothelioma, and Ocular Melanomas, also associated with poor prognoses (Fig. 9B–F). Here, SYT11 is linked to cancer.